Edition:
United States

Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

44.84USD
22 Sep 2017
Change (% chg)

$0.43 (+0.97%)
Prev Close
$44.41
Open
$44.39
Day's High
$45.21
Day's Low
$44.13
Volume
175,940
Avg. Vol
107,309
52-wk High
$55.95
52-wk Low
$43.66

Chart for

About

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $1,007.69
Shares Outstanding(Mil.): 22.69
Dividend: 0.14
Yield (%): 1.26

Financials

  Industry Sector
P/E (TTM): -- 175.94 16.34
EPS (TTM): -- -- --
ROI: -- 9.47 14.66
ROE: -- 14.70 14.00

BRIEF-Abaxis reports Q1 earnings per share $0.28

* Abaxis reports financial performance for the first quarter of fiscal 2018 and declares quarterly cash dividend

Jul 27 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $131.39 -0.36
Roche Holding Ltd. (ROG.S) CHF248.00 -1.00
Roche Holding Ltd. (RO.S) CHF248.00 -1.00
Abbott Laboratories (ABT.N) $52.51 +1.08
Alere Inc (ALR.N) $50.35 0.00
Alere Inc (ALR_pb.N) $398.64 +0.39
VCA Inc (WOOF.OQ) -- --
IDEXX Laboratories, Inc. (IDXX.OQ) $157.50 +1.74
Heska Corp (HSKA.OQ) $89.36 -0.12

Earnings vs. Estimates